Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Imbruvica/Gazyva combo improves PFS in CLL patients

pharmatimesJuly 11, 2018

Tag: / Gazyva/ ibrutinib/ obinutuzumab/ CLL/ // / / , / Gazyva/ ibrutinib/ obinutuzumab/ CLL/ // / / , / Gazyva/ ibrutinib/ obinutuzumab/ CLL/ // / /

PharmaSources Customer Service